Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
7.36
+0.18 (2.51%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $2.31 billion as of April 17, 2025. Its market cap has increased by 24.80% in one year.
Market Cap
2.31B
Enterprise Value
4.79B
1-Year Change
24.80%
Ranking
Category
Stock Price
$7.36
Market Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has decreased from $5.76B to $2.31B, a decrease of -59.96%. That is a compound annual growth rate of -12.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 2.28B | -7.03% |
| Dec 31, 2024 | 2.45B | 31.89% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |